Submit Deal

XENOTECH

Summary

XenoTech has almost 30 years' experience as a specialty global Contract Research Organization (CRO) specializing in ADME/DMPK/DDI testing of potential drug candidates. Utilized by top pharma companies, biotechs, and numerous other organizations.

Deals Overview

Total Deals1

Valued Deals0

Total Value-

Avg. Deal Size-

Market Context

Senior Management

Darren Warren
CEO

Sort

12 Sep 2022|United States|Biotechnology

Target: XENOTECH

Bidder: BIOIVT

5 Service Providers

1 Target | 3 Bidder | 1 Vendor

7 Dealmakers

1 Target | 5 Bidder | 1 Vendor

n/a

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy